Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 5Osteosarcoma 4Prostatic Neoplasms 3Multiple Myeloma 3Breast Neoplasms 3With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Chondrosarcoma 1CLDN18.2-positive Gastric Adenocarcinoma 1Bone Diseases 1Adenocarcinoma 1

Interventions

Gemcitabine 3Docetaxel 3belinostat 2Fluorouracil 2Bevacizumab 2venetoclax 1toripalimab 1tanespimycin 1ivosidenib 1itacitinib 1durvalumab 1capivasertib 1birinapant 1baricitinib 1Zoledronic Acid 1Thalidomide 1Taxes 1Radiotherapy 1Paclitaxel 1Medicare Part B 1Leucovorin 1Irinotecan 1Immunoglobulin G 1INCB039110 1IFL protocol 1Filgrastim 1Disulfides 1Cisplatin 1Chemotherapy, Adjuvant 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Chondrosarcoma × Zoledronic Acid × Clear all
NCT03173976 2025-11-06

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

University of Iowa

Phase 1 Active not recruiting
17 enrolled
Sarcoma

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡